The findings suggest that selective reversiblealdehyde dehydrogenase 2 inhibitors may have the therapeutic potential to reduce binge eating of palatable foods in clinical populations.
2
GS 455534 is a highly selective reversiblealdehyde dehydrogenase 2 inhibitor that has been shown to reduce alcohol and cocaine intake in rats.